Purdue Pharma files Chapter 11 after “onslaught of lawsuits”
Despite having no funded debt or judgment creditors, OxyContin maker Purdue Pharma has filed for Chapter 11 bankruptcy protection in New York, with Davis Polk & Wardwell and Dechert advising.
To read more
Subscribe to Global Restructuring Review
Subscribe & start reading now!
GRR is a daily information service providing cross-border insolvency and restructuring news, features and events.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10